Detalhe da pesquisa
1.
Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.
Blood
; 136(17): 1980-1983, 2020 10 22.
Artigo
Inglês
| MEDLINE | ID: mdl-32518951
2.
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Cancer Discov
; 13(9): 1982-1997, 2023 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37249512
3.
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study.
Clin Cancer Res
; 28(6): 1087-1097, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34921024
4.
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
Cancer Discov
; 10(4): 552-567, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32001516
5.
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Nat Med
; 24(10): 1504-1506, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30275569
6.
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.
Nat Med
; 24(10): 1499-1503, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30275568
7.
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 24(5): 563-571, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29713085
8.
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 27(3): 561, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33547459